Gene · 10657
Papers1,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic Mutations Profiling in Genes Other than BRCA and TP53 Increasing Breast Carcinoma Risk Among Pakistani Patients. | Rev Recent Clin Trials | 2026 | 40755100 | PubTator, text mining | PubMed |
| CD44v5 enhances the IL-4/IL-4Rα/STAT6/SAM68 aix inducing M2 polarization and promoting triple-negative breast cancer progression. | Cancer Biol Ther | 2025 | 41319154 | PubTator, text mining | PubMed |
| Roles of RNA Structures in the Genome Translation of (+) Sense RNA Viruses. | Viruses | 2025 | 41305427 | PubTator, text mining | PubMed |
| Hypoxia-Induced circPRELID2 Promotes Gastric Cancer Metastasis by Facilitating ZEB2 Translation via PCBP1 O-GlcNAcylation. | Adv Sci (Weinh) | 2025 | 41117067 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation-related genes in the immune microenvironment and diagnosis of focal segmental glomerulosclerosis and minimal change disease. | Ren Fail | 2025 | 41111226 | PubTator, text mining | PubMed |
| Online Conference "Chronic Viral Infections and Cancer, Openings for Vaccines and Cure" VIRCAN2024, Monitoring the Progress. | Vaccines (Basel) | 2025 | 41012143 | PubTator, text mining | PubMed |
| The multifaceted role of the viral 2A protease in enterovirus replication and antagonism of host antiviral responses. | PLoS Pathog | 2025 | 40875754 | PubTator, text mining | PubMed |
| Role of ebv-circRPMS1-p53 interaction in the proliferation and clinical progression of Epstein-Barr virus-associated gastric carcinoma. | Virus Res | 2025 | 40846151 | PubTator, text mining | PubMed |
| DNA Methylation Status of Regulatory Regions of Apoptosis-Associated Genes in Dystropy «Huntington's Disease-Non-Small Cell Lung Cancer». | Epigenomes | 2025 | 40843670 | PubTator, text mining | PubMed |
| Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer. | J Med Virol | 2025 | 40832845 | PubTator, text mining | PubMed |
| TRIM6 ablation reverses ICB resistance in MSS gastric cancer by unleashing cGAS-STING-dependent antitumor immunity. | J Exp Clin Cancer Res | 2025 | 40817248 | PubTator, text mining | PubMed |
| RNA-interactome capture identifies SRSF3 as a key protein for herpesviral gene expression. | PNAS Nexus | 2025 | 40809086 | PubTator, text mining | PubMed |
| Cancer stem cells: landscape, challenges and emerging therapeutic innovations. | Signal Transduct Target Ther | 2025 | 40759634 | PubTator, text mining | PubMed |
| Exon Skipping of Ste20-Like Kinase Enhances Glycolysis and Tumor Progression by Activating Enolase 1-Mediated Phosphoenolpyruvate Production. | Cancer Res | 2025 | 40748995 | PubTator, text mining | PubMed |
| Caerin 1.1/1.9 interfere KHDRBS1-DDX5 regulatory axis to induce IL-18 mediated pyroptosis in a HeLa cell tumour model. | Sci Rep | 2025 | 40738927 | PubTator, text mining | PubMed |
| Tr-KIT Downstream Regulation by YY1 and NFYA Transcription Factors Knockdown in Prostate Cancer Cells. | Genes Chromosomes Cancer | 2025 | 40716089 | PubTator, text mining | PubMed |
| Multi-target RNA interference: A disruptive next-generation strategy for precision treatment of rheumatoid arthritis. | Int Immunopharmacol | 2025 | 40394795 | PubTator, text mining | PubMed |
| Insufficiency of 40S ribosomal proteins, RPS26 and RPS25, negatively affects biosynthesis of polyglycine-containing proteins in fragile-X associated conditions. | Elife | 2025 | 40377206 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma. | Sci Rep | 2025 | 40374855 | PubTator, text mining | PubMed |
| catGRANULE 2.0: accurate predictions of liquid-liquid phase separating proteins at single amino acid resolution. | Genome Biol | 2025 | 39979996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10657/papers?page=2